Whilst the immediate involvement of MEK/ERK was neither excluded nor confirmed, in breast cancer it has been reported that MEK/ERK signaling can directly regulate TWIST1/2 via c-Jun N-terminal kinases (JNK) in response to transforming growth factor (TGF)-β stimuli [101]. This evidence concerns the gene MAP2K7 and breast cancer.